Copyright
©The Author(s) 2020.
World J Gastroenterol. Jun 21, 2020; 26(23): 3225-3235
Published online Jun 21, 2020. doi: 10.3748/wjg.v26.i23.3225
Published online Jun 21, 2020. doi: 10.3748/wjg.v26.i23.3225
Figure 5 Inhibition of sodium glucose cotransporter 2 reduces serum leptin levels.
A: Serum leptin levels in C57BL/6J. B: Serum leptin levels in Kimba mice treated with dapagliflozin. C: Serum leptin levels in Kimba mice treated with empagliflozin. n = 4-7 mice/group; aP < 0.05; All data represented as mean ± SE.
- Citation: Herat LY, Ward NC, Magno AL, Rakoczy EP, Kiuchi MG, Schlaich MP, Matthews VB. Sodium glucose co-transporter 2 inhibition reduces succinate levels in diabetic mice. World J Gastroenterol 2020; 26(23): 3225-3235
- URL: https://www.wjgnet.com/1007-9327/full/v26/i23/3225.htm
- DOI: https://dx.doi.org/10.3748/wjg.v26.i23.3225